Anti-CD38 antibodies for treatment of acute myeloid leukemia
US-12286474-B2 · Apr 29, 2025 · US
This page is not indexed by search engines while we improve data quality.
Doshi Parul patents
Doshi Parul is listed as an inventor on 24 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Doshi Parul |
| Total patents | 24 |
| First publication | Sep 3, 2015 |
| Latest publication | Apr 29, 2025 |
Notable patents
Publications ranked by popularity score, then publication date.
Anti-CD38 Antibodies for Treatment of Light Chain Amyloidosis and Other CD38-Positive Hematological Malignancies
US-2025011458-A1 · Jan 9, 2025 · US
Combination Therapies with Anti-CD38 Antibodies
US-2025011457-A1 · Jan 9, 2025 · US
Anti-CD38 antibodies for treatment of light chain amyloidosis and other CD38-positive hematological malignancies
US-12091466-B2 · Sep 17, 2024 · US
Combination therapies with anti-CD38 antibodies
US-12060432-B2 · Aug 13, 2024 · US
Anti-CD38 antibodies for treatment of acute lymphoblastic leukemia
US-11713355-B2 · Aug 1, 2023 · US
Combination therapies with anti-cd38 antibodies
US-2021061920-A1 · Mar 4, 2021 · US
Anti-CD38 Antibodies for Treatment of Acute Myeloid Leukemia
US-2021047401-A1 · Feb 18, 2021 · US
Anti-CD38 Antibodies for Treatment of Light Chain Amyloidosis and Other CD38-Positive Hematological Malignancies
US-2020407459-A1 · Dec 31, 2020 · US
Combination therapies with anti-CD38 antibodies
US-10800851-B2 · Oct 13, 2020 · US
Recent patents
Latest publications not already listed above.
Anti-CD38 antibodies for treatment of acute myeloid leukemia
US-10793630-B2 · Oct 6, 2020 · US
Anti-CD38 antibodies for treatment of light chain amyloidosis and other CD38-positive hematological malignancies
US-10766965-B2 · Sep 8, 2020 · US
Anti-CD38 Antibodies for Treatment of Acute Lymphoblastic Leukemia
US-2020223936-A1 · Jul 16, 2020 · US
Combination therapies for heme malignancies with anti-CD38 antibodies and survivin inhibitors
US-10668149-B2 · Jun 2, 2020 · US
Anti-CD38 antibodies for treatment of acute lymphoblastic leukemia
US-10556961-B2 · Feb 11, 2020 · US
Anti-CD38 Antibodies for Treatment of Acute Lymphoblastic Leukemia
US-2017320961-A1 · Nov 9, 2017 · US
Anti-CD38 antibodies for treatment of acute lymphoblastic leukemia
US-9732154-B2 · Aug 15, 2017 · US
Combination Therapies with Anti-CD38 Antibodies
US-2017174780-A1 · Jun 22, 2017 · US
Combination therapies with anti-CD38 antibodies
US-9603927-B2 · Mar 28, 2017 · US
Anti-CD38 Antibodies for Treatment of Light Chain Amyloidosis and Other CD28-Positive Hematological Malignancies
US-2017008966-A1 · Jan 12, 2017 · US
Combination therapies for heme malignancies with Anti-CD38 antibodies and survivin inhibitors
US-2016367663-A1 · Dec 22, 2016 · US
Anti-CD38 Antibodies for Treatment of Acute Myeloid Leukemia
US-2016222106-A1 · Aug 4, 2016 · US
Anti-CD38 Antibodies for Treatment of Acute Lymphoblastic Leukemia
US-2015246975-A1 · Sep 3, 2015 · US
Combination Therapies with Anti-CD38 Antibodies
US-2015246123-A1 · Sep 3, 2015 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Janssen Biotech Inc | 24 |
| Tufts Medical Ct Inc | 5 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| C07K16/2896 | 24 |
| A61P35/02 | 24 |
| C07K2317/732 | 22 |
| C07K2317/56 | 22 |
| A61P43/00 | 19 |